¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

(¿Â¶óÀÎ)´ëÇÑÁø´Ü°Ë»çÀÇÇÐȸ 2022³â Ãá°è½ÉÆ÷Áö¾ö(2ÀÏÂ÷) : 2022-03-25

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
(¿Â¶óÀÎ)´ëÇÑÁø´Ü°Ë»çÀÇÇÐȸ 2022³â Ãá°è½ÉÆ÷Áö¾ö(2ÀÏÂ÷) : 2022-03-25
±³À°ÀÏÀÚ : 2022-03-25
±³À°Àå¼Ò : ¿Â¶óÀÎ ½Ç½Ã°£ »ýÁß°è  
±³À°ÁÖÁ¦ : (¿Â¶óÀÎ)´ëÇÑÁø´Ü°Ë»çÀÇÇÐȸ 2022³â Ãá°è½ÉÆ÷Áö¾ö(2ÀÏÂ÷)
ÁÖÃÖ±â°ü : ´ëÇÑÁø´Ü°Ë»çÀÇÇÐȸ
´ã´çÀÚ : ±èÈñ¼ø
¿¬¶ôó : 02-795-9914  
À̸ÞÀÏ : kscp3@kams.or.kr      
±³À°Á¾·ù : Áø´Ü°Ë»çÀÇÇаú      
Âü¼®¿¹»óÀοø : 700¸í
Èñ¸ÁÆòÁ¡ : 6Á¡   (ÀÏ¹Ý 4Á¡ / Çʼö 2Á¡)  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 12 ½Ã°£ 20ºÐ  
¼¼ºÎ¼ö°­·á : 250,000¿ø      
ºñ°í Á¤È¸¿ø-10¸¸¿ø/ÁØȸ¿ø-8¸¸¿ø/ºñȸ¿ø 25¸¸¿ø      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 03-25 Channel 2 09:00~09:20 (Symposium 5) ±¹³» ¼öŹ°Ë»ç½Ç¿¡¼­ ¹ß°ßµÇ´Â ÁÖ¿ä °¨¿°±Õ ³»¼º ÃßÀÌ  ±è¹ÎÁø(¾¾Á¨ÀÇ·áÀç´Ü) 
±³À°½Ã°£ 03-25 Channel 2 09:20~09:40 (Symposium 5) ¹Ì»ý¹° Ç×±ÕÁ¦ ³»¼ºÀÇ ºÐÀÚÁø´Ü  ±èâ±â(Àç)¼­¿ïÀÇ°úÇבּ¸¼Ò) 
±³À°½Ã°£ 03-25 Channel 2 09:40~10:00 (Symposium 5) COVID-19 À¯Çà¿¡ µû¸¥ È£Èí±â ¹× ¼ÒÈ­±â °¨¿°º´ÀÇ º¯È­  Á¶ÁøÈñ(ÀÌ¿øÀÇ·áÀç´Ü) 
±³À°½Ã°£ 03-25 Channel 2 10:00~10:30 (Symposium 5) ±¹³» ÁÖ¿ä ¼öŹ °Ë»ç½ÇÀÇ COVID-19 ºÐ¼®  ÀüÀ¯¶ó(³ì½ÊÀÚÀÇ·áÀç´Ü) 
±³À°½Ã°£ 03-25 Channel 1 09:00~09:30 (WorkShop 5) ¸¸¼º°ñ¼ö¼º¹éÇ÷º´ÀÇ º´Àΰú ÃֽŠÁöħ¿¡ ±Ù°ÅÇÑ Áø´Ü  Á¶¿µ¿í(¿ï»êÀÇ´ë) 
±³À°½Ã°£ 03-25 Channel 1 09:30~10:00 (WorkShop 5) ¹«Ä¡·á °üÇØ¿Í BCR-ABL1 Á¤·® Ç¥ÁØÈ­¸¦ À§ÇÑ ³ë·Â  ±èÇö¿µ(¼º±Õ°üÀÇ´ë) 
±³À°½Ã°£ 03-25 Channel 1 10:00~10:30 (WorkShop 5) ¸¸¼º°ñ¼ö¼º¹éÇ÷º´¿¡¼­ Â÷¼¼´ë¿°±â¼­¿­ºÐ¼®ÀÇ »õ·Î¿î ¿ªÇÒ  ±èÇý¸²(ºÎ»êÀÇ´ë) 
±³À°½Ã°£ 03-25 Channel 1 10:50~11:40 (Plenary Session 2) Critical role of pathologists in genomic era: Correlating genotype with phenotype in hematologic malignancies  Olga K Weinberg(Dept. of Pathology, UT Southwestern Medical Center, USA) 
±³À°½Ã°£ 03-25 Channel 1 11:50~12:30 (Education Workshop 4) Enhanced Liver Fibrosis(ELF) Test in Diagnostic Pathways  ¹ÚÀ±¹Ì(Áö¸à½º Çï½Ã´Ï¾î½º) 
±³À°½Ã°£ 03-25 Channel 2 11:50~12:30 (Education Workshop 5) Discovery of syndromic testing utility in specific patient populations  È«ÁöÇý(ºñ¿À¸Þ¸®À¸) 
±³À°½Ã°£ 03-25 Channel 3 11:50~12:05 (Education Workshop 6) Arkray ADAMS A1c HA-8190V Æò°¡  ÀÌÁØÈñ(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 03-25 Channel 3 12:05~12:30 (Education Workshop 6) Arkray ADAMS A1c HA-8190V ¹Ìµé¿þ¾î ½Ã½ºÅÛÀÇ ÀÓ»óÀû À¯¿ë¼º Æò°¡  À±¿©¹Î(°Ç±¹ÀÇ´ë) 
±³À°½Ã°£ 03-25 Channel 1 13:20~13:50 (Workshop 6) À¯¼¼Æ÷°Ë»çÀÇ »õ·Î¿î CLSI °¡À̵å¶óÀÎ ¼Ò°³, &quotH62, Validation of Assays Performed by Flow Cytometry, 1st Edition"  ÀÓÁöÇâ(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 03-25 Channel 1 13:50~14:20 (Workshop 6) ¸²ÇÁ±¸ ¾ÆÇü : 5Á¾À¸·Î ÃæºÐÇÑ°¡?  ½Å°æÈ­(ºÎ»êÀÇ´ë) 
±³À°½Ã°£ 03-25 Channel 1 14:20~14:50 (Workshop 6) À¯¼¼Æ÷ºÐ¼®¿¡¼­ÀÇ °íÂ÷¿ø, ´ÙÁßÀÎÀÚ µ¥ÀÌÅͺм®¹ý ¼Ò°³  À±ÅÂÇö(ÇѾç´ëÇб³ È­Çаú&µðÁöÅÐÀÇ·áÀ¶ÇÕÇаú) 
±³À°½Ã°£ 03-25 Channel 3 13:20~13:50 (Workshop 7) ±¹³» ÀÇ·á°ü·Ã°¨¿° ÇöȲ  ±èÅüö(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 03-25 Channel 3 13:50~14:20 (Workshop 7) ±¹³» °¨¿°°ü¸® ½ÇÅ Á¶»ç ÇöȲ  ÀÌÀç°©(ÇѸ²ÀÇ´ë) 
±³À°½Ã°£ 03-25 Channel 3 14:20~14:50 (Workshop 7) Äڷγª19 °¨¿°°ü¸®¸¦ À§ÇÑ Áø´Ü °Ë»ç  È«±âÈ£(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 03-25 Channel 3 14:50~15:20 (Workshop 7) Äڷγª19 °¨¿°°ü¸®¸¦ À§ÇÑ È¯°æ °ü¸®  Á¤¼±¿µ(°Ç¾ç´ë °£È£´ë) 
±³À°½Ã°£ 03-25 Channel 1 15:20~15:40 (Symposium 6) Á¦ 5ÆÇ ¼öÇ÷°¡À̵å¶óÀÎÀÇ ÁÖ¿ä °³Á¤ »çÇ×  Á¶´ö(¼º±Õ°üÀÇ´ë) 
±³À°½Ã°£ 03-25 Channel 1 15:40~16:00 (Symposium 6) ¼öÇ÷ÀûÁ¤¼º Æò°¡ ÇöȲ ¹× Àü¸Á  ±èµ¿¼÷(½ÉÆò¿ø) 
±³À°½Ã°£ 03-25 Channel 1 16:00~16:20 (Symposium 6) ¼öÇ÷°ü¸®½ÇÀÇ Ç¥ÁØ ¿î¿µ  ¼­µ¿Èñ(·¦Áö³ë¹Í½º) 
±³À°½Ã°£ 03-25 Channel 1 16:20~16:40 (Symposium 6) ¼öÇ÷°ü¸®½Ç ¿î¿µ °æÇè  ±è½Å¿µ(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 03-25 Channel 2 15:43~16:03 (Symposium 7) EP07, ÀÓ»óÈ­Çп¡¼­ÀÇ °£¼· Æò°¡  Á¤Àç¿ì(µ¿±¹ÀÇ´ë) 
±³À°½Ã°£ 03-25 Channel 2 15:44~16:04 (Symposium 7) EP34, °Ëü Èñ¼®°ú ÷°¡¸¦ ÅëÇÑ È®ÀåÃøÁ¤±¸°£ ¼³Á¤ ¹× °ËÁ¤  Á¤Åµ¿(ÀÌÈ­ÀÇ´ë) 
±³À°½Ã°£ 03-25 Channel 2 15:45~16:05 (Symposium 7) POCT14, ÀÀ°í °Ë»ç¿Í Ç×ÀÀ°í ¸ð´ÏÅ͸µÀ» À§ÇÑ ÇöÀå °Ë»ç  ÀÌ´©¸®(ÇѸ²ÀÇ´ë) 
±³À°½Ã°£ 03-25 Channel 2 15:46~16:06 (Symposium 7) QMS12, °Ë»ç½Ç Çâ»óÀ» À§ÇÑ Áú°ü¸®ÁöÇ¥ÀÇ °³¹ß°ú È°¿ë  ÇѹÎÁ¦(ÇѸ²ÀÇ´ë) 
±³À°½Ã°£ 03-25 Channel 2 15:47~16:07 (Symposium 7) QMS23, ÀϹݰ˻çÀåºñ ¼º´ÉÀûÇÕ¼º È®ÀÎ, »ç¿ë ¹× À¯Áö°ü¸®  ¹Ú°æÁø(»ï¼ºÃ¢¿øº´¿ø) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" (¿Â¶óÀÎ)´ëÇÑÁø´Ü°Ë»çÀÇÇÐȸ 2022³â Ãá°è½ÉÆ÷Áö¾ö(2ÀÏÂ÷) : 2022-03-25""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ±¹¸³Áß¾ÓÀÇ·á¿ø °ñ´Ù°øÁõ Áø´Ü ¹× Ä¡·á¸¦ À§ÇÑ ¿öÅ©¼ó : 2022-03-26
´ÙÀ½±Û â¿ø°æ»ó±¹¸³´ëÇб³º´¿ø À̺ñÀÎÈÄ°ú ±Ý¿ä¼¼¹Ì³ª : 2022-03-25
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
303 ¼­¿ï Á¦42ȸ 2018³â ´ëÇÑÀϹݰúÀÇ»çȸ ÇÏ°è ¿¬¼ö°­Á : 2018-08-19 0 429 2018-08-08
302 ¼­¿ï ¼­¿ï´ëÇб³º´¿ø Á¦25Â÷ ¼­¿ï½ÉÆ÷Áö¿ò : 2018-08-19 0 540 2018-08-08
301 ¼­¿ï Á¦4ȸ ´ëÇѽŰæ¿Ü°úº´¿øÇùÀÇȸ Çмú´ëȸ : 2018-08-19 0 1,266 2018-08-08
300 ¼­¿ï ´ëÇѳëÀκ´ÇÐȸ Á¦ 38Â÷ ÀÎÁ¤ÀÇ ¿¬¼ö°­Á : 2018-08-19 0 751 2018-08-08
299 ¼­¿ï 2018 ÀÇ·áÄ¿¹Â´ÏÄÉÀÌ¼Ç ±³À°Àü·« ¿öÅ©¼ó : 2018-08-18 0 527 2018-08-08
298 °æ±â ´ëÇÑôÃßÁ¾¾ç¿¬±¸È¸ Á¦18Â÷ Çмú´ëȸ : 2018-08-18 0 1,018 2018-08-08
297 ¼­¿ï ´ëÇÑÁ¤Çü¿Ü°úÇÐȸ iTHA (Innovation & Technology in Hip Athroplasty) : 2018-08-18 0 1,199 2018-08-08
296 ¼­¿ï ´ëÇÑÈäºÎ¿Ü°úÇÐȸ Heart Valve Disease Symposium 2018 : 2018-08-18 0 604 2018-08-08
295 ¼­¿ï °æÈñ´ëÇб³º´¿ø 2018 Kyung Hee Neurosurgery Symposium (ÀÓ¿µÁø ±³¼ö´Ô Á¤³â±â³ä ½ÉÆ÷Áö¿ò) : 2018-08-18 0 1,538 2018-08-08
294 °æ±â ´ëÇÑ°³¿øÀÇÇùÀÇȸ °­¿øÁöȸ ½ÉÆ÷Áö¿ò : 2018-08-18 0 620 2018-08-08
293 ¼­¿ï ´ëÇÑÈäºÎ¿Ü°úÇÐȸ Heart Valve Disease Symposium 2018 : 2018-08-17 0 1,086 2018-08-08
292 ¼­¿ï °æÈñ´ëÇб³º´¿ø Á¦11ȸ »êºÎÀΰú-¼Ò¾Æû¼Ò³â°ú ¼±»ý´Ôµé°ú ÇÔ²²ÇÏ´Â ¿ù·ÊÁý´ãȸ : 2018-08-17 0 915 2018-08-08
291 °­¿ø °­¿øµµÀÇ»çȸ ÀúÇ÷´çÁõ¿¡ ´ëÇÑ °íÂû : 2018-08-16 0 553 2018-08-08
290 ¼­¿ï ´ëÇѽÅÀåÇÐȸ 2018 Update on CKD-MBD: Phosphorous and Magnesium in health and disease : 2018-09-30 0 1,148 2018-07-28
289 °æ±â ÇѸ²´ëÇб³¼º½Éº´¿ø °³¿øÀǸ¦ À§ÇÑ ¼Ò¾ÆÁúȯ : 2018-09-29 0 856 2018-07-28
1371 | 1372 | 1373 | 1374 | 1375 | 1376 | 1377 | 1378 | 1379 | 1380
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷